Tumor cells can obtain energy via glycolysis and pentose phosphate pathways, thereby enhancing their resistance to chemotherapeutic drugs [11, 38]. Our study found that MND1 attenuated the toxic effects of oxaliplatin on the GC cells. This evidence concerns the gene MND1 and gastric cancer.